20 LATEST RESOURCES (256 INDEXED)
Exploring Mental Health Comorbidities and Opioid Agonist Treatment Coverage among People in Prison: A National Cohort Study 2010–2019 · July 2023
Articles
Drug and Alcohol Dependence
Psychopharmacological Treatment of Disruptive Behavior in Youths: Systematic Review and Network Meta-Analysis · April 2023
Articles
Scientific Reports
The Use of Benzodiazepines and the Mental Health of Women in Prison: A Cross-Sectional Study · March 2023
Articles
Scientific Reports
Detection of Methadone and Buprenorphine in Urine Samples from Inmates of German Prisons · February 2023
Articles
Frontiers in Psychiatry
Cariprazine in Offender Patient with Acute Psychosis and Aggressive Behavior: Case Report · December 2022
Articles
Psychiatry Research Case Reports
Interest without Uptake: A Mixed-Methods Analysis of Methadone Utilization in Kyrgyz Prisons · October 2022
Articles
PLOS ONE
Overactive, Aggressive, Disruptive and Agitated Behavior Associated with the Use of Psychotropic Medications in Schizophrenia · August 2022
Articles
Schizophrenia Research
OROS-Methylphenidate to Reduce ADHD Symptoms in Male Prisoners Aged 16-25 Years: A RCT · July 2022
Publications (Books-Reports)
National Institute for Health and Care Research
Randomised Controlled Trial of the Short-Term Effects of Osmotic-Release Oral System Methylphenidate on Symptoms and Behavioural Outcomes in Young Male Prisoners with Attention Deficit Hyperactivity Disorder: CIAO-II Study · June 2022
Articles
British Journal of Psychiatry
Can Pediatric Bipolar Disorder Be Successfully Treated When Comorbid with Conduct Disorder? A Secondary Analysis of Clinical Trials of Risperidone, Olanzapine, Quetiapine, Ziprasidone, and Aripiprazole · May 2022
Abstracts
Journal of Psychopharmacology
A Pilot Implementation Study to Scale-Up Methadone in Incarcerated Persons with Opioid Use Disorder and Retain Them on Treatment After Release in Moldova · April 2022
Articles (Manuscripts-Versions)
PubMed Central>International Journal on Drug Policy
Perceptions and Experiences Toward Extended-Release Buprenorphine among Persons Leaving Jail with Opioid Use Disorders Before and During COVID-19: An In-Depth Qualitative Study · January 2022
Articles
Addiction Science and Clinical Practice
Selective Serotonin Reuptake Inhibitors (SSRIs) and Their Effect on Patient Aggression in Adult Patients in a State Psychiatric Facility: A Retrospective Analysis · January 2022
Articles
NCBI>Innovations in Clinical Neuroscience
Buprenorphine Induction in a Rural Maryland Detention Center during COVID-19: Implementation and Preliminary Outcomes of a Novel Telemedicine Treatment Program for Incarcerated Individuals with Opioid Use Disorder · October 2021
Articles
Frontiers in Psychiatry
Neural Responses to Fluoxetine in Youths with Disruptive Behavior and Trauma Exposure: A Pilot Study · October 2021
Articles
Journal of Child and Adolescent Psychopharmacology
Comparison of Treatment Retention of Adults with Opioid Addiction Managed with Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release from Jail · September 2021
Articles
JAMA Network Open
Transition from Methadone to Subcutaneous Buprenorphine Depot in Patients with Opioid Use Disorder in Custodial Setting: A Case Series · August 2021
Articles
American Journal of Drug and Alcohol Abuse
Functional Connectivity in Antipsychotic-Treated and Antipsychotic-Naive Patients with First-Episode Psychosis and Low Risk of Self-Harm or Aggression: A Secondary Analysis of a Randomized Clinical Trial · June 2021
Articles
JAMA Psychiatry